Severe cholestasis due to disseminated histoplasmosis under adalimumab-containing immunosuppressive therapy

Clin Res Hepatol Gastroenterol. 2013 Sep;37(4):e105-7. doi: 10.1016/j.clinre.2013.03.008. Epub 2013 May 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Aged
  • Anti-Inflammatory Agents / adverse effects*
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Cholestasis / chemically induced*
  • Cholestasis / microbiology*
  • Female
  • Histoplasmosis / complications*
  • Humans
  • Immunosuppression Therapy
  • Immunosuppressive Agents / adverse effects*
  • Severity of Illness Index

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents
  • Adalimumab